论文部分内容阅读
目的:观察镇肝熄风汤联合常规药物治疗高血压性脑出血术后患者的临床疗效。方法:纳入119例肝阳上亢型高血压性脑出血术后患者,按住院号查随机表分为对照组和观察组,2组患者均成功行微创手术后,采用硝苯地平缓释片控制血压,观察组在此基础上,术后2天以镇肝熄风汤治疗。经治疗2月,比较2组患者治疗前后的血压情况及术后再出血率。结果:治疗后,2组血压值均较治疗前降低(P<0.05);观察组收缩压、舒张压均低于对照组(P<0.05)。对照组术后再出血16例,发生率26.7%;观察组术后再出血5例,发生率8.5%。2组术后再出血率比较,差异有统计学意义(P<0.05)。结论:在常规西医疗法基础上应用镇肝熄风汤治疗肝阳上亢型高血压性脑出血术后患者,可有效控制患者的血压,预防术后再出血的发生。
Objective: To observe the clinical efficacy of Zhengan Xifeng Decoction combined with conventional drugs in patients with hypertensive intracerebral hemorrhage. Methods: One hundred and nineteen cases of hypertensive intracerebral hemorrhage with liver-yang hyperactivity were divided into control group and observation group according to the randomized hospitalization table. After the minimally invasive operation, both groups were treated with sustained-release nifedipine Film control blood pressure, the observation group on this basis, 2 days after treatment with Zhengan Xifengtang. After 2 months of treatment, blood pressure and postoperative rebleeding rate were compared between two groups before and after treatment. Results: After treatment, the blood pressure in both groups were lower than before treatment (P <0.05). The systolic and diastolic blood pressure in the observation group were lower than those in the control group (P <0.05). In the control group, 16 cases were rebleeding after the operation, with a rate of 26.7%. In the observation group, there were 5 cases of rebleeding, the incidence rate was 8.5%. There were significant differences in the rate of rebleeding between the two groups (P <0.05). Conclusion: The application of Zhengan Xifeng Decoction on patients with hyperthyroidism-induced hypertensive intracerebral hemorrhage on the basis of conventional western medicine can effectively control the blood pressure and prevent the occurrence of postoperative hemorrhage.